TY - UNPB
T1 - Post-infectious inflammatory disease in MIS-C features elevated cytotoxicity signatures and autoreactivity that correlates with severity
AU - Ramaswamy, Anjali
AU - Brodsky, Nina N
AU - Sumida, Tomokazu S
AU - Comi, Michela
AU - Asashima, Hiromitsu
AU - Hoehn, Kenneth B
AU - Li, Ningshan
AU - Liu, Yunqing
AU - Shah, Aagam
AU - Ravindra, Neal G
AU - Bishai, Jason
AU - Khan, Alamzeb
AU - Lau, William
AU - Sellers, Brian
AU - Bansal, Neha
AU - Sparks, Rachel
AU - Unterman, Avraham
AU - Habet, Victoria
AU - Rice, Andrew J
AU - Catanzaro, Jason
AU - Chandnani, Harsha
AU - Lopez, Merrick R.
AU - Kaminski, Naftali
AU - Dela Cruz, Charles S
AU - Tsang, John S
AU - Wang, Zuoheng
AU - Yan, Xiting
AU - Kleinstein, Steven H
AU - van Dijk, David
AU - Pierce, Richard W
AU - Hafler, David A
AU - Lucas, Carrie L
PY - 2020/12/4
Y1 - 2020/12/4
N2 - Multisystem inflammatory syndrome in children (MIS-C) is a life-threatening post-infectious complication occurring unpredictably weeks after mild or asymptomatic SARS-CoV2 infection in otherwise healthy children. Here, we define immune abnormalities in MIS-C compared to adult COVID-19 and pediatric/adult healthy controls using single-cell RNA sequencing, antigen receptor repertoire analysis, unbiased serum proteomics, and in vitro assays. Despite no evidence of active infection, we uncover elevated S100A-family alarmins in myeloid cells and marked enrichment of serum proteins that map to myeloid cells and pathways including cytokines, complement/coagulation, and fluid shear stress in MIS-C patients. Moreover, NK and CD8 T cell cytotoxicity genes are elevated, and plasmablasts harboring IgG1 and IgG3 are expanded. Consistently, we detect elevated binding of serum IgG from severe MIS-C patients to activated human cardiac microvascular endothelial cells in culture. Thus, we define immunopathology features of MIS-C with implications for predicting and managing this SARS-CoV2-induced critical illness in children.
AB - Multisystem inflammatory syndrome in children (MIS-C) is a life-threatening post-infectious complication occurring unpredictably weeks after mild or asymptomatic SARS-CoV2 infection in otherwise healthy children. Here, we define immune abnormalities in MIS-C compared to adult COVID-19 and pediatric/adult healthy controls using single-cell RNA sequencing, antigen receptor repertoire analysis, unbiased serum proteomics, and in vitro assays. Despite no evidence of active infection, we uncover elevated S100A-family alarmins in myeloid cells and marked enrichment of serum proteins that map to myeloid cells and pathways including cytokines, complement/coagulation, and fluid shear stress in MIS-C patients. Moreover, NK and CD8 T cell cytotoxicity genes are elevated, and plasmablasts harboring IgG1 and IgG3 are expanded. Consistently, we detect elevated binding of serum IgG from severe MIS-C patients to activated human cardiac microvascular endothelial cells in culture. Thus, we define immunopathology features of MIS-C with implications for predicting and managing this SARS-CoV2-induced critical illness in children.
UR - https://www.medrxiv.org/content/medrxiv/early/2020/12/04/2020.12.01.20241364.full.pdf
UR - http://www.ncbi.nlm.nih.gov/pubmed/33300011
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC7724682
UR - https://www.mendeley.com/catalogue/d817edac-4589-35b8-b9bc-0a253e78f3e1/
U2 - 10.1101/2020.12.01.20241364
DO - 10.1101/2020.12.01.20241364
M3 - Preprint
C2 - 33300011
BT - Post-infectious inflammatory disease in MIS-C features elevated cytotoxicity signatures and autoreactivity that correlates with severity
PB - medRxiv
ER -